Literature DB >> 9737319

Metabolic abnormalities and use of HIV-1 protease inhibitors.

E Martinez, J Gatell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9737319     DOI： 10.1016/S0140-6736(05)60719-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Metabolic Complications of HIV and AIDS.

Authors:  Alison Strawford; Marc K. Hellerstein
Journal:  Curr Infect Dis Rep       Date:  2001-04       Impact factor: 3.725

2.  HIV protease inhibitors, the lipodystrophy syndrome and polycystic ovary syndrome--is there a link?

Authors:  J D Wilson; R J Dunham; A H Balen
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

3.  Ultrasonography in lesions of the carotid vessels in HIV positive patients.

Authors:  M Cristofaro; S Cicalini; E Busi Rizzi; V Schininà; N Petrosillo; C Bibbolino
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

Review 4.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

Review 5.  Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.

Authors:  Joel da Cunha; Luciana Morganti Ferreira Maselli; Ana Carolina Bassi Stern; Celso Spada; Sérgio Paulo Bydlowski
Journal:  World J Virol       Date:  2015-05-12

Review 6.  Lipodystrophy syndrome in patients with HIV infection: quality of life issues.

Authors:  E Martínez; M A Garcia-Viejo; L Blanch; J M Gatell
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 7.  Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS.

Authors:  Ovidiu Galescu; Amrit Bhangoo; Svetlana Ten
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 8.  Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence.

Authors:  Amanda L Willig; Edgar Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2016-10       Impact factor: 5.071

9.  Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors.

Authors:  Naufil Alam; Mario Cortina-Borja; Tessa Goetghebuer; Magdalena Marczynska; Alessandra Vigano; Claire Thorne
Journal:  J Acquir Immune Defic Syndr       Date:  2012-03-01       Impact factor: 3.731

10.  Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study.

Authors:  Cecile Cames; Lea Pascal; Aissatou Ba; Hélène Mbodj; Baly Ouattara; Ndeye-Fatou Diallo; Philippe Msellati; Ngagne Mbaye; Haby Sy Signate; Stephane Blanche; Aminata Diack
Journal:  BMC Infect Dis       Date:  2018-08-06       Impact factor: 3.090
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.